Taking a Newer, Faster, Intranasal Route: A Narrative Review of Transitioning to a Less-Invasive Rescue Treatment for Seizure Clusters

References

• Cloyd J, Haut S, Carrazana E, Rabinowicz AL. Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters. Epilepsia. 2021;62(4):846–856. doi:10.1111/epi.16847
   PubMed Web of Science ®Google Scholar
• Haut SR, Nabbout R. Recognizing seizure clusters in the community: the path to uniformity and individualization in nomenclature and definition. Epilepsia. 2022;63(suppl):S6–S13. doi:10.1111/epi.17346
   PubMedGoogle Scholar
• Cereghino JJ, Mitchell WG, Murphy J, Kriel RL, Rosenfeld WE, Trevathan E. Treating repetitive seizures with a rectal diazepam formulation: a randomized study. The North American diastat study group. Neurology. 1998;51(5):1274–1282. doi:10.1212/WNL.51.5.1274
   PubMed Web of Science ®Google Scholar
• Mitchell WG, Conry JA, Crumrine PK, et al. An open-label study of repeated use of diazepam rectal gel (Diastat) for episodes of acute breakthrough seizures and clusters: safety, efficacy, and tolerance. North American Diastat Group Epilepsia. 1999;40(11):1610–1617.
   Google Scholar
• Hua S. Physiological and pharmaceutical considerations for rectal drug formulations. Front Pharmacol. 2019;10:1196.
   PubMed Web of Science ®Google Scholar
• Bausch Health US, LLC. Diastat^® C-IV (Diazepam Rectal Gel) [Prescribing Information]. Bridgewater, NJ: Bausch Health US, LLC; 2023.
   Google Scholar
• Penovich P, Wheless JW, Hogan RE, et al. Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: results from an exit survey of a phase 3, open-label, repeat-dose safety study. Epilepsy Behav. 2021;121(Pt A):108013. doi:10.1016/j.yebeh.2021.108013
   PubMed Web of Science ®Google Scholar
• Meng TC, Szaflarski JP, Chen L, et al. Psychosocial outcomes of repeated treatment of seizure clusters with midazolam nasal spray: results of a phase 3, open-label extension trial. Epilepsy Behav. 2023;138:108989. doi:10.1016/j.yebeh.2022.108989
   PubMed Web of Science ®Google Scholar
• Dean P, O’Hara K, Brooks L, Shinnar R, Bougher G, Santilli N. Managing acute seizures: new rescue delivery option and resources to assist school nurses. NASN Sch Nurse. 2021;36(6):346–354. doi:10.1177/1942602X211026333
   PubMedGoogle Scholar
• Neurelis, Inc. VALTOCO^® (Diazepam Nasal Spray) [Prescribing Information]. San Diego, CA: Neurelis, Inc.; 2023.
   Google Scholar
• UCB, Inc. Nayzilam^® (Midazolam Nasal Spray) [Prescribing Information]. Smyrna, GA: UCB, Inc.; 2023.
   Google Scholar
• Wheless JW, Miller I, Hogan RE, et al. Final results from a phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy. Epilepsia. 2021;62(10):2485–2495. doi:10.1111/epi.17041
   PubMed Web of Science ®Google Scholar
• Hogan RE, Gidal BE, Koplowitz B, Koplowitz LP, Lowenthal RE, Carrazana E. Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers. Epilepsia. 2020;61(3):455–464. doi:10.1111/epi.16449
   PubMed Web of Science ®Google Scholar
• Detyniecki K, Van Ess PJ, Sequeira DJ, Wheless JW, Meng TC, Pullman WE. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-A randomized, double-blind, placebo-controlled trial. Epilepsia. 2019;60(9):1797–1808. doi:10.1111/epi.15159
   PubMed Web of Science ®Google Scholar
• Wheless JW, Meng TC, Van Ess PJ, Detyniecki K, Sequeira DJ, Pullman WE. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters: an open-label extension trial. Epilepsia. 2019;60(9):1809–1819. doi:10.1111/epi.16300
   PubMed Web of Science ®Google Scholar
• Rabinowicz AL, Faught E, Cook DF, Carrazana E. Implications of seizure-cluster treatment on healthcare utilization: use of approved rescue medications. Neuropsychiatr Dis Treat. 2022;18:2431–2441. doi:10.2147/NDT.S376104
   PubMed Web of Science ®Google Scholar
• Faught E. Economic aspects of treating seizure clusters. Epilepsia. 2022;63(suppl 1):S45–54. doi:10.1111/epi.17340
   PubMedGoogle Scholar
• Tarquinio D, Dlugos D, Wheless JW, Desai J, Carrazana E, Rabinowicz AL. Safety of diazepam nasal spray in children and adolescents with epilepsy: results from a long-term phase 3 safety study. Pediatr Neurol. 2022;132:50–55. doi:10.1016/j.pediatrneurol.2022.04.011
   PubMed Web of Science ®Google Scholar
• Peters JM, Puri V, Segal E, Misra SN, Rabinowicz AL, Carrazana E. Concomitant cannabidiol does not impact safety and effectiveness of diazepam nasal spray for seizure clusters: post hoc analysis of a phase 3 safety study. Epilepsy Behav. 2023;144:109248. doi:10.1016/j.yebeh.2023.109248
   PubMed Web of Science ®Google Scholar
• Segal EB, Tarquinio D, Miller I, et al. Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: an interim subgroup analysis from a phase 3, long-term, open-label safety study. Epilepsia. 2021;62(6):1442–1450. doi:10.1111/epi.16901
   PubMed Web of Science ®Google Scholar
• Vazquez B, Wheless J, Desai J, Rabinowicz AL, Carrazana E. Lack of observed impact of history or concomitant treatment of seasonal allergies or rhinitis on repeated doses of diazepam nasal spray administered per seizure episode in a day, safety, and tolerability: interim results from a phase 3, open-label, 12-month repeat-dose safety study. Epilepsy Behav. 2021;118:107898. doi:10.1016/j.yebeh.2021.107898
   PubMed Web of Science ®Google Scholar
• Miller I, Wheless JW, Hogan RE, et al. Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: interim results from a phase 3, long-term, open-label, repeat-dose safety study. Epilepsia Open. 2021;6(3):504–512. doi:10.1002/epi4.12494
   PubMedGoogle Scholar
• Cook DF, Gustin RM, Misra SN, et al. Effectiveness of diazepam nasal spray does not vary across times of day associated with meals and fasting in patients with seizure clusters: post hoc results from a long-term, open-label safety study. Nashville, TN: Presented at: AES; 2022.
   Google Scholar
• Cramer JA, Faught E, Davis C, Misra SN, Carrazana E, Rabinowicz AL. Quality-of-life results in adults with epilepsy using diazepam nasal spray for seizure clusters from a long-term, open-label safety study. Epilepsy Behav. 2022;134:108811. doi:10.1016/j.yebeh.2022.108811
   PubMed Web of Science ®Google Scholar
• Misra SN, Sperling MR, Rao VR, et al. Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters. Epilepsia. 2022;63(10):2684–2693. doi:10.1111/epi.17385
   PubMed Web of Science ®Google Scholar
• O’Hara K, Dewar S, Bougher G, Dean P, Misra SN, Desai J. Overcoming barriers to the management of seizure clusters: ease of use and time to administration of rescue medications. Expert Rev Neurother. 2023;23(5):425–432. doi:10.1080/14737175.2023.2206568
   PubMed Web of Science ®Google Scholar
• Chhabra R, Gupta R, Gupta LK. Intranasal midazolam versus intravenous/rectal benzodiazepines for acute seizure control in children: a systematic review and meta-analysis. Epilepsy Behav. 2021;125:108390. doi:10.1016/j.yebeh.2021.108390
   PubMed Web of Science ®Google Scholar
• Nunley S, Glynn P, Rust S, Vidaurre J, Albert DVF, Patel AD. A hospital-based study on caregiver preferences on acute seizure rescue medications in pediatric patients with epilepsy: intranasal midazolam versus rectal diazepam. Epilepsy Behav. 2019;92:53–56. doi:10.1016/j.yebeh.2018.12.007
   PubMed Web of Science ®Google Scholar
• Knoester PD, Jonker DM, Van Der Hoeven RT, et al. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. Br J Clin Pharmacol. 2002;53(5):501–507. doi:10.1046/j.1365-2125.2002.01588.x
   PubMed Web of Science ®Google Scholar
• de Haan GJ, van der Geest P, Doelman G, Bertram E, Edelbroek P. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia. 2010;51(3):478–482. doi:10.1111/j.1528-1167.2009.02333.x
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. Pharmacokinetics study of VALTOCO® in pediatric subjects with epilepsy (NCT05076838). Available from: https://clinicaltrials.gov/ct2/show/NCT05076838. Accessed August 16, 2022.
   Google Scholar